Avacta Group PLC (AVCT)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

58.00p

Buy

60.00p

arrow-down-2.60p (-4.22%)

Prices updated at 13 Nov 2026, 16:29 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation prote ...
FTSE All-Share
arrow-up0.27%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Ian Hughes
CEO
Dr. Christina Marie Coughlin
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
75
Head office
58 Wood Lane
London
United Kingdom
W12 7RZ
mobile
+44 2039110353
letter
investors@avacta.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Patrick V.J.J. Vink, M.D.
Non-Executive Director, Deputy Chairman and Senior Independent Director
-
Mr. Richard Ian Hughes
Non-Executive Director, Chairman
-
Ms. Darlene Marie Deptula-Hicks
Non-Executive Director
-
Mr. Mats Blom
Non-Executive Director
-
Mr. David John Bryant
Non-Executive Director
-
Dr. Christina Marie Coughlin
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
AXA Investment Managers UK Ltd4,758,156
UTM IM GBP AXA Framlington Biotech4,758,156
FIL Life Insurance Limited4,670,617
Undly L&G Future World UK Eq Idx Fd4,670,617
Unicorn Asset Management Ltd4,300,000

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
09 Oct 2026Purchase
09 Oct 2026Purchase
09 Oct 2026Purchase
09 Oct 2026Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.